Therefore, we next tested whether mobilization of MLLr-B-ALL blasts to PB with the NG2 antagonist Ch’ase (Fig. 4) or 7.1 MoAb (Fig. 5) synergizes with VxL treatment in PDX models of MLLr-B-ALL. Here, CSPG4 is linked to acute lymphoblastic leukemia.